Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Fluolink AB maintains 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This prosecution activity is concentrated under 1 distinct examiner and 1 distinct art unit, indicating a very specific technical focus for the company's current patent filings. The absence of multiple pending matters or diverse art units suggests that the company is currently prioritizing a single line of mechanical or medical device development.
The busiest examiner for the portfolio is HOEKSTRA, JEFFREY GERBEN, who is responsible for the 1 busiest examiner pending office action currently active. As the sole examiner assigned to the company's workload, their specific examination style and interpretation of the relevant statutes will dictate the outcome of this filing. The reliance on 1 distinct examiner means the applicant's immediate success is tied directly to the performance and pace of this one official.
Because the portfolio consists of only 1 pending office action, the administrative burden of tracking deadlines and examiner communications is minimal. The focus on 1 distinct art unit allows for a specialized prosecution approach, though it lacks the breadth found in larger portfolios. Practitioners should monitor the specific tendencies of the Medical Devices & Mechanical Engineering unit to which this single matter is assigned to ensure a successful outcome.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOEKSTRA, JEFFREY GERBEN | 1 | 56.5% | +39.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18246705 | PROBE-GUIDE FOR IDENTIFYING AND HARVESTING A BIOPSY | HOEKSTRA, JEFFREY GERBEN | 38d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18246705 | PROBE-GUIDE FOR IDENTIFYING AND HARVESTING A BIOPSY | HOEKSTRA, JEFFREY GERBEN | 38d overdue |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18246705 | PROBE-GUIDE FOR IDENTIFYING AND HARVESTING A BIOPSY | HOEKSTRA, JEFFREY GERBEN | 3791 | §102§103§112 | Final Rejection | 38d overdue | Pending | Mar 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial